Index S&P 500
P/E 17.05
EPS (ttm) 7.66
Insider Own 0.66%
Shs Outstand 1.73B
Perf Week 1.19%
Market Cap 226.54B
Forward P/E 22.90
EPS next Y 5.70
Insider Trans -6.54%
Shs Float 1.72B
Perf Month 17.56%
Income 13.39B
PEG 1.62
EPS next Q 1.07
Inst Own 77.67%
Short Float 1.06%
Perf Quarter 12.17%
Sales 41.95B
P/S 5.40
EPS this Y 10.40%
Inst Trans -0.66%
Short Ratio 3.14
Perf Half Y 18.86%
Book/sh 22.94
P/B 5.69
EPS next Y 10.61%
ROA 7.85%
Short Interest 18.24M
Perf Year 17.31%
Cash/sh 4.49
P/C 29.09
EPS next 5Y 10.51%
ROE 14.87%
52W Range 99.71 - 132.50
Perf YTD 15.47%
Dividend Est. 2.37 (1.82%)
P/FCF 34.93
EPS past 5Y 30.08%
ROI 25.44%
52W High -1.43%
Beta 0.71
Dividend TTM 2.24 (1.72%)
Quick Ratio 1.14
Sales past 5Y 6.15%
Gross Margin 57.79%
52W Low 30.99%
ATR (14) 2.47
Dividend Ex-Date Jan 15, 2025
Current Ratio 1.60
EPS Y/Y TTM 11.65%
Oper. Margin 16.44%
RSI (14) 64.18
Volatility 1.48% 2.29%
Employees 114000
Debt/Eq 0.38
Sales Y/Y TTM 4.59%
Profit Margin 31.91%
Recom 1.79
Target Price 135.41
Option/Short Yes / Yes
LT Debt/Eq 0.32
EPS Q/Q 479.65%
Payout 29.22%
Rel Volume 0.64
Prev Close 131.79
Sales Surprise -0.52%
EPS Surprise 0.32%
Sales Q/Q 7.16%
Earnings Jan 22 BMO
Avg Volume 5.81M
Price 130.61
SMA20 2.83%
SMA50 9.63%
SMA200 16.22%
Trades
Volume 3,719,680
Change -0.90%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-08-24 Initiated
Oppenheimer
Outperform
$130
Sep-19-24 Initiated
Piper Sandler
Overweight
$131
Jul-30-24 Downgrade
Edward Jones
Buy → Hold
May-30-24 Initiated
Goldman
Buy
$121
Jul-21-23 Upgrade
Wolfe Research
Underperform → Peer Perform
May-30-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$112
Apr-20-23 Reiterated
Wolfe Research
Underperform
$107 → $103
Apr-20-23 Reiterated
UBS
Buy
$117 → $130
Apr-20-23 Reiterated
Raymond James
Outperform
$116 → $123
Apr-20-23 Reiterated
JP Morgan
Overweight
$118 → $122
Apr-20-23 Reiterated
Bernstein
Outperform
$132 → $133
Apr-20-23 Reiterated
Barclays
Overweight
$125 → $127
Mar-29-23 Initiated
UBS
Buy
$117
Oct-26-22 Initiated
Mizuho
Neutral
$105
Oct-18-22 Initiated
Barclays
Overweight
$118
Oct-12-22 Initiated
Jefferies
Hold
$110
Jul-06-22 Initiated
Wolfe Research
Underperform
$95
Mar-02-22 Resumed
BofA Securities
Buy
$140
Jan-27-22 Reiterated
UBS
Buy
$138 → $142
Jan-27-22 Reiterated
Raymond James
Outperform
$150 → $143
Show Previous Ratings
Feb-14-25 01:00PM
Feb-13-25 09:29AM
06:35AM
Feb-12-25 09:17AM
Feb-11-25 12:23PM
(Pharmaceutical Technology)
09:00AM
Loading…
09:00AM
06:03AM
Feb-10-25 08:45AM
04:20AM
04:04AM
Feb-08-25 06:48PM
Feb-07-25 04:56PM
(Investor's Business Daily)
08:45AM
Feb-06-25 08:48PM
Feb-04-25 11:27AM
06:02AM
Loading…
06:02AM
Feb-03-25 07:45AM
Feb-02-25 04:08PM
Feb-01-25 01:14PM
(The Wall Street Journal)
Jan-31-25 02:42PM
Jan-29-25 10:15PM
11:26AM
Jan-28-25 09:00AM
06:02AM
Jan-27-25 12:01PM
Jan-26-25 01:25PM
Jan-24-25 07:14PM
Jan-23-25 07:06AM
04:15AM
02:03AM
01:26AM
Loading…
01:26AM
(Thomson Reuters StreetEvents)
Jan-22-25 05:45PM
04:03PM
(Investor's Business Daily)
01:15PM
11:40AM
11:32AM
11:13AM
10:18AM
(Investor's Business Daily)
10:17AM
09:30AM
08:50AM
(Investor's Business Daily)
08:15AM
07:12AM
(Associated Press Finance)
07:02AM
07:00AM
06:01AM
Jan-21-25 07:00PM
06:00AM
Jan-19-25 06:21AM
05:00AM
Jan-15-25 11:33AM
09:00AM
06:01AM
Jan-13-25 06:00PM
Jan-08-25 07:16PM
06:01AM
Jan-06-25 06:00PM
09:38AM
09:00AM
Jan-03-25 07:36PM
09:40AM
Jan-02-25 09:00AM
08:00AM
Jan-01-25 12:45PM
09:00AM
Dec-30-24 06:00PM
Dec-28-24 06:59AM
04:15AM
Dec-25-24 10:15AM
06:01AM
05:30AM
Dec-24-24 05:50PM
Dec-23-24 06:00PM
Dec-19-24 06:00AM
Dec-18-24 05:15AM
Dec-17-24 05:50PM
04:03PM
07:00AM
Dec-13-24 01:21PM
10:58AM
Dec-12-24 09:00AM
(The Wall Street Journal)
09:00AM
(The Wall Street Journal)
Dec-11-24 05:50PM
06:01AM
Dec-09-24 10:38PM
Dec-07-24 09:14PM
Dec-05-24 05:50PM
09:30AM
Dec-04-24 09:00AM
Nov-29-24 05:50PM
Nov-27-24 06:00AM
Nov-25-24 04:05PM
07:00AM
Nov-22-24 12:21PM
Nov-20-24 09:00AM
Nov-19-24 09:30AM
Nov-18-24 10:00AM
06:00AM
Nov-16-24 07:19PM
Nov-14-24 06:19AM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Ford Robert B CHAIRMAN AND CEO Feb 05 '25 Option Exercise 38.40 285,388 10,958,899 505,447 Feb 07 05:51 PM Ford Robert B CHAIRMAN AND CEO Feb 05 '25 Sale 131.17 285,388 37,435,200 220,059 Feb 07 05:51 PM Robert B. Ford Officer Feb 05 '25 Proposed Sale 131.17 285,388 37,435,238 Feb 05 06:52 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 29 '25 Option Exercise 38.40 131,360 5,044,224 316,166 Jan 31 07:16 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 30 '25 Option Exercise 38.40 58,428 2,243,635 243,234 Jan 31 07:16 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 29 '25 Sale 128.35 131,360 16,859,675 184,806 Jan 31 07:16 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 30 '25 Sale 128.07 58,428 7,482,629 184,806 Jan 31 07:16 PM Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Jan 30 '25 Option Exercise 38.40 23,771 912,806 149,468 Jan 31 07:08 PM Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Jan 30 '25 Sale 128.50 23,771 3,054,574 125,697 Jan 31 07:08 PM Morrone Louis H. EXECUTIVE VICE PRESIDENT Jan 28 '25 Sale 127.39 2,644 336,819 0 Jan 30 07:33 PM Hubert L. Allen Officer Jan 30 '25 Proposed Sale 128.07 58,428 7,482,628 Jan 30 05:33 PM Daniel Gesua Sive Salvadori Officer Jan 30 '25 Proposed Sale 128.50 23,771 3,054,573 Jan 30 05:26 PM Hubert L. Allen Officer Jan 29 '25 Proposed Sale 128.35 131,360 16,859,675 Jan 29 05:30 PM Funck, Jr. Robert E. Officer Nov 04 '24 Proposed Sale 120.00 15,000 1,800,000 Nov 04 04:02 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Oct 21 '24 Option Exercise 47.00 157,421 7,398,787 342,227 Oct 23 05:10 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Oct 21 '24 Sale 117.04 157,421 18,424,298 184,806 Oct 23 05:10 PM ALLEN HUBERT L Officer Oct 21 '24 Proposed Sale 118.89 157,421 18,715,783 Oct 21 04:08 PM Ford Robert B CHAIRMAN AND CEO Sep 12 '24 Option Exercise 47.19 141,679 6,685,975 361,738 Sep 13 05:24 PM Ford Robert B CHAIRMAN AND CEO Sep 12 '24 Sale 116.41 141,679 16,493,218 220,059 Sep 13 05:24 PM Robert B. Ford Officer Sep 12 '24 Proposed Sale 116.41 141,679 16,492,852 Sep 12 06:20 PM MCCOY JOHN A. JR. VICE PRESIDENT Sep 04 '24 Sale 114.83 27 3,100 18,681 Sep 04 07:52 PM Funck, Jr. Robert E. Officer Sep 04 '24 Proposed Sale 115.00 30,000 3,450,000 Sep 04 04:04 PM Funck, Jr. Robert E. EXECUTIVE VICE PRESIDENT May 10 '24 Option Exercise 47.00 10,097 474,559 221,438 May 14 05:35 PM Funck, Jr. Robert E. EXECUTIVE VICE PRESIDENT May 10 '24 Sale 104.57 10,097 1,055,819 211,341 May 14 05:35 PM Earnhardt Lisa D EXECUTIVE VICE PRESIDENT May 07 '24 Sale 106.25 22,852 2,428,119 61,462 May 08 05:00 PM Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 963 114,116 125,697 Mar 04 07:18 PM Morrone Louis H. EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 801 94,918 62,968 Mar 04 07:14 PM Moreland Mary K EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 676 80,106 91,260 Mar 04 07:09 PM MCCOY JOHN A. JR. VICE PRESIDENT Mar 01 '24 Sale 118.50 472 55,932 18,760 Mar 04 07:05 PM Earnhardt Lisa D EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 694 82,239 84,314 Mar 04 06:50 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 853 101,080 184,806 Mar 04 06:39 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Feb 23 '24 Option Exercise 59.94 12,500 749,250 91,204 Feb 27 06:13 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Feb 23 '24 Sale 120.00 12,500 1,500,000 78,704 Feb 27 06:13 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite